Xcout IntelKintai
Xi'an Kintai Biotech Inc. is a major manufacturer and supplier of herbal extracts and pharmaceutical intermediates based in Xi'an, China. The company serves the global health industry by producing high-quality natural plant extracts derived from regions rich in natural resources.
Subscribe to see Kintai’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kintai at a glance
Kintai is a biotech company headquartered in China. Its most recent funding round, Series A, raised $11M in July 2026. Xcout tracks 1 named person at Kintai, including Ignasi Llorens (CEO and co-founder). Xcout recorded 8 job postings from Kintai in the last 90 days, naming tools such as HubSpot, Salesforce.
Kintai leadership
- Ignasi LlorensCEO and co-founder
Kintai funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $11M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Kintai
Xcout recorded 8 job postings from Kintai in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Kintai's job postings
The weekly hiring trend, the roles and locations behind it — see Kintai's hiring signals →
Recent Kintai news
Investors
Tech stack
Kintai competitors
A few of Kintai's closest competitors — see the full list of competitors and alternatives →
Natac is a biotechnology company headquartered in Madrid, Spain, specializing in the research, development, and sustainable production of natural plant extracts and nutraceutical ingredients.
Plant Advanced Technologies (PAT) is a plant biotechnology company that produces rare and innovative active ingredients for the cosmetic, pharmaceutical, and agrochemical markets. The company develops proprietary extraction technologies and participates in collaborative research projects to supply high-value plant-based compounds while preserving biodiversity.
Bide Pharmatech Co., Ltd. is a chemical reagent company that provides pharmaceutical intermediates, molecular building blocks, catalysts, ligands, inhibitors, and custom synthesis services for scientific researchers and pharmaceutical enterprises.
Wuhan Healthgen Biotechnology Corp. develops and manufactures plant-derived recombinant human serum albumin and related biopharmaceutical materials. Its products serve biopharmaceutical manufacturers, including applications in cell culture, drug formulation, vaccines, and diagnostics.
Established in 1985 and headquartered in Kobe, Japan, KNC Laboratories Co., Ltd. focuses on the innovation, creation, and fabrication of organic chemical products. Their extensive range of offerings is utilized across various industries, including pharmaceuticals, electronic chemistry, agrochemicals, energy, and environmental management. Furthermore, the company provides critical support services for both medicinal compounds and advanced functional chemicals.
Emerald Health Bioceuticals Inc. develops biology-based life science solutions focused on enhancing human, animal, and plant life. The company utilizes advanced research, fermentation, biomanufacturing, and process development to create safe and sustainable products for its partners and customers.
Get Kintai's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kintai in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access